Phase I trial of a glypican-3-derived peptide vaccine for advanced hepatocellular carcinoma: immunologic evidence and potential for improving overall survival

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Yu SawadaTetsuya Nakatsura

Abstract

The carcinoembryonic antigen glypican-3 (GPC3) is an ideal target of anticancer immunotherapy against hepatocellular carcinoma (HCC). In this nonrandomized, open-label, phase I clinical trial, we analyzed the safety and efficacy of GPC3 peptide vaccination in patients with advanced HCC. Thirty-three patients with advanced HCC underwent GPC3 peptide vaccination (intradermal injections on days 1, 15, and 29 with dose escalation). The primary endpoint was the safety of GPC3 peptide vaccination. The secondary endpoints were immune response, as measured by IFN-γ ELISPOT assay, and the clinical outcomes tumor response, time to tumor progression, and overall survival (OS). GPC3 vaccination was well-tolerated. One patient showed a partial response, and 19 patients showed stable disease 2 months after initiation of treatment. Four of the 19 patients with stable disease had tumor necrosis or regression that did not meet the criteria for a partial response. Levels of the tumor markers α-fetoprotein and/or des-γ-carboxy prothrombin temporarily decreased in nine patients. The GPC3 peptide vaccine induced a GPC3-specific CTL response in 30 patients. Furthermore, GPC3-specific CTL frequency after vaccination correlated with OS. OS was signifi...Continue Reading

References

Apr 1, 1996·Immunology Today·M Browning, P Krausa
Mar 7, 2002·Journal of Pediatric Hematology/oncology·J A ToretskyD Schlessinger
Jun 6, 2003·Biochemical and Biophysical Research Communications·Tetsuya NakatsuraYasuharu Nishimura
Jul 10, 2003·Gastroenterology·Mariana CapurroJorge Filmus
Feb 12, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Takashi MineHideaki Yamana
Dec 30, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Tetsuya NakatsuraYasuharu Nishimura
Mar 12, 2005·CA: a Cancer Journal for Clinicians·D Max ParkinPaola Pisani
Apr 6, 2005·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Tetsuya Nakatsura, Yasuharu Nishimura
May 6, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hiroyuki KomoriYasuharu Nishimura
May 6, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Lisa H ButterfieldJames S Economou
Oct 19, 2006·Journal of Hepatology·Tim F GretenFirouzeh Korangy
May 13, 2008·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Sarit Aviel-RonenSerge Jothy
Jul 25, 2008·The New England Journal of Medicine·Josep M LlovetUNKNOWN SHARP Investigators Study Group
Nov 5, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Daniel H PalmerDavid H Adams
Mar 31, 2009·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Daichi MaedaMasashi Fukayama
Jun 6, 2009·Cancer Science·Hirofumi ShirakawaTetsuya Nakatsura
Nov 4, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Eiji KakazuTooru Shimosegawa
Feb 23, 2010·Seminars in Liver Disease·Riccardo Lencioni, Josep M Llovet
Feb 26, 2011·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Manabu MorimotoKatsuaki Tanaka
Mar 23, 2011·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Yanhui XuDavid E Kaplan
Apr 12, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Eishiro MizukoshiShuichi Kaneko

❮ Previous
Next ❯

Citations

Jan 29, 2013·International Journal of Oncology·Tatsuaki IwamaTetsuya Nakatsura
Mar 13, 2014·Journal of Translational Medicine·Atsushi ArugaMasakazu Yamamoto
Mar 28, 2013·Journal of Gastroenterology·I-Pei ChenMasakazu Yamamoto
Oct 10, 2015·Journal of Hepatology·Renumathy DhanasekaranLewis R Roberts
Dec 7, 2013·Expert Review of Vaccines·Mehrdad Talebian YazdiSjoerd H van der Burg
Feb 7, 2016·Current Opinion in Immunology·Maria TagliamonteLuigi Buonaguro
Nov 6, 2015·Cancer·James J HardingGhassan K Abou-Alfa
Jun 22, 2015·Cancer Immunology, Immunotherapy : CII·Luigi Buonaguro, UNKNOWN HEPAVAC Consortium
Oct 21, 2015·Nature Reviews. Gastroenterology & Hepatology·Jesús PrietoBruno Sangro
Apr 11, 2013·Journal of Hepatology·Martin F Sprinzl, Peter R Galle
May 3, 2014·International Journal of Cancer. Journal International Du Cancer·Vanessa GauttierSophie Conchon
Jun 10, 2015·British Journal of Cancer·K SiderasJ Kwekkeboom
Mar 4, 2015·Journal of Hepatology·Oxana V Makarova-RusherTim F Greten
Feb 6, 2014·Oncoimmunology·Fernando ArandaLorenzo Galluzzi
Dec 18, 2012·Oncoimmunology·Yu SawadaTetsuya Nakatsura
Nov 22, 2012·Oncoimmunology·Lorenzo GalluzziGuido Kroemer
Nov 8, 2013·Human Vaccines & Immunotherapeutics·Hiroyuki SuzukiMitsukazu Gotoh
Feb 28, 2013·Human Vaccines & Immunotherapeutics·Daisuke NobuokaTetsuya Nakatsura
Apr 22, 2015·Diagnostic Pathology·Oguz AydinFiliz Karagoz
Nov 5, 2014·Virchows Archiv : an International Journal of Pathology·Maria TretiakovaXiming J Yang
Jun 21, 2016·Nihon Rinshō Men'eki Gakkai kaishi = Japanese journal of clinical immunology·Tetsuya Nakatsura
Jul 31, 2012·Cancer Letters·Li-Jun WuJian Wu
Aug 26, 2016·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Yasunari Nakamoto
Sep 30, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Yuta YoshizakiKenji Kono

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.